4-amino-1,8-naphthalimide has been researched along with Arteriosclerosis in 1 studies
4-amino-1,8-naphthalimide: inhibits ADP-ribosylation; sometimes abreviated as 4-AN;
Arteriosclerosis: Thickening and loss of elasticity of the walls of ARTERIES of all sizes. There are many forms classified by the types of lesions and arteries involved, such as ATHEROSCLEROSIS with fatty lesions in the ARTERIAL INTIMA of medium and large muscular arteries.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kloster, KL | 1 |
| Judy, MM | 1 |
| Matthews, JL | 1 |
| Utecht, RE | 1 |
| Burbach, JA | 1 |
| Vaska, KJ | 1 |
1 other study available for 4-amino-1,8-naphthalimide and Arteriosclerosis
| Article | Year |
|---|---|
Preferential localization of varying forms of photoactive 1, 8-naphthalimide compounds within the atheromatous arterial wall.
Topics: 1-Naphthylamine; Animals; Arteriosclerosis; Carotid Arteries; Endothelium, Vascular; In Vitro Techni | 2000 |